As the US stimulus bill nears passage, the focus on federal government funding of R&D has increased. It is hoped that the stimulus funding will make up some of the declines in US federal R&D funding this fiscal year (see IBO 10/15/08). The drop in federal R&D funding, when adjusted for inflation, over the past […]
Last year was another year of upheaval for R&D operations at the top pharmaceutical companies. Big pharma continued to undergo extensive changes as firms sought to increase the odds of successful drug discovery and development, while reducing R&D costs, in order to maintain profitability as drug patents expire. In addition, new CEOs at Eli Lilly […]
Next-generation sequencing is among the fastest-growing markets in the life science instrument market, with 2009 instrument demand estimated to increase more than 40%. The advent of next-generation sequencing has birthed the need for novel approaches to sample preparation (for the purpose of this article, sample preparation encompasses purification, fragmentation, target capture and enrichment prior to […]
In 2007, China’s R&D spending rose 23.5% to CNY 371 billion ($48.8 billion) to account for 1.49% of GDP. The national government‘s R&D spending grew 25.2 % to CNY 42.5 billion to make up 4.25% of its expenditures. R&D by companies, government-affiliated research institutes, and colleges and universities accounted for 72.3%, 18.5% and 8.5% of […]
Following Pfizer’s plan to acquire Wyeth and Roche’s bid for Genentech, other big pharmaceutical firms may be considering major acquisitions. Sanofi-Aventis is reported to be interested in purchasing Bristol-Myers Squibb (BMS). The companies currently comarket Plavix. However, BMS’s future patent expirations and changes in leadership at Sanofi-Aventis could deter the deal. Merck & Co. has […]
Billerica, MA 2/2/09—Millipore has agreed to acquire Guava Technologies, a provider of microcapillary flow cytometers, for $22.6 million. Guava recorded 2008 sales of $21.9 million. The acquisition is expected to be slightly accretive to Millipore’s non-GAAP EPS during 2009. “Our vision is to make flow cytometry less expensive, easier to use, and more accessible for […]
Loveland, CO 2/10/09—Hach announced that it has acquired OPS Systems and the assets of WaterEye. Based in Rio Rancho, New Mexico, OPS provides water-related reporting and analysis, preventive maintenance and LIMS (laboratory information management solutions) software solutions for water, wastewater and industrial plant operations. WaterEye provides web-based information management solutions. As a result of the […]
Company Announcements Nanosurf AG appointed RL Artal as its official agent for Hungary and Anamet SRO as its distributor for the Czech Republic and Slovakia. Nikon Instruments signed a value-added reseller agreement to sell the ChromoDynamics’ HSi-300 Hyperspectral Imaging System with its Eclipse 90i and Ti series of microscopes. The System addresses the removal of […]
The International Service for the Acquisition of Agri-Biotech Applications (ISAAA) reports that the world’s hectarage of biotech crops increased 19.4% to 125 million hectares in 2008. Cropnosis estimates that the market value (based on the sale price of the seed and technology fees) of biotech crops grew 8.7% in 2008 to $7.5 billion to account […]
Company Announcements Under a research agreement, NuGEN Technologies will develop a Roche NimbleGen array application for small, degraded and compromised samples for use with its WT-Ovation technology. Biogemma will use Roche NimbleGen’s Sequence Capture technology to develop new technologies for large-scale genomic marker discovery in plants. Febit announced a strategic collaboration with In-Q-Tel for the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
